Evidence map›Paper›PMID 31850344›Full record

ReviewFrontiers in cell and developmental biology2019

Agephagy - Adapting Autophagy for Health During Aging.

Eleanor R Stead, Jorge I Castillo-Quan, Victoria Eugenia Martinez Miguel, Celia Lujan, Robin Ketteler, Kerri J Kinghorn, Ivana Bjedov

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Eleanor R SteadUCL Cancer Institute, University College London, London, United Kingdom.
Jorge I Castillo-QuanSection on Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, United States.
Victoria Eugenia Martinez MiguelUCL Cancer Institute, University College London, London, United Kingdom.
Celia LujanUCL Cancer Institute, University College London, London, United Kingdom.
Robin KettelerMRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.
Kerri J KinghornInstitute of Healthy Ageing, University College London, London, United Kingdom.
Ivana BjedovUCL Cancer Institute, University College London, London, United Kingdom.
University College London · GBCRUK Lung Cancer Centre of Excellence · GBJoslin Diabetes Center · US

Funding

Medical Research Council MC_EX_G0800785Medical Research Council MR/M02492X/1
6 · The paper itself

Abstract

Autophagy is a major cellular recycling process that delivers cellular material and entire organelles to lysosomes for degradation, in a selective or non-selective manner. This process is essential for the maintenance of cellular energy levels, components, and metabolites, as well as the elimination of cellular molecular damage, thereby playing an important role in numerous cellular activities. An important function of autophagy is to enable survival under starvation conditions and other stresses. The majority of factors implicated in aging are modifiable through the process of autophagy, including the accumulation of oxidative damage and loss of proteostasis, genomic instability and epigenetic alteration. These primary causes of damage could lead to mitochondrial dysfunction, deregulation of nutrient sensing pathways and cellular senescence, finally causing a variety of aging phenotypes. Remarkably, advances in the biology of aging have revealed that aging is a malleable process: a mild decrease in signaling through nutrient-sensing pathways can improve health and extend lifespan in all model organisms tested. Consequently, autophagy is implicated in both aging and age-related disease. Enhancement of the autophagy process is a common characteristic of all principal, evolutionary conserved anti-aging interventions, including dietary restriction, as well as inhibition of target of rapamycin (TOR) and insulin/IGF-1 signaling (IIS). As an emerging and critical process in aging, this review will highlight how autophagy can be modulated for health improvement.

Indexed as

aginganti-aging drugsautophagyDNA damageinsulin/IGF-1 signalingmitophagyproteostasistarget of rapamycin

Identifiers

PMID31850344
PMCPMC6892982
OpenAlexW2990697870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.